Ireland
--:--IST
Priya Life Science Sponsor trial record
Sponsor · clinical trials

Umraniye Education and Research Hospital clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our Turkey register with Umraniye Education and Research Hospital as lead sponsor. Synced 14 Nov 2026
6Current trials
3Recruiting now
1Drug in these trials
1Trial register
At a glance

Umraniye Education and Research Hospital is the lead sponsor of 6 current clinical trials in our Turkey register. 3 are recruiting patients now. The most common phase is Not applicable. The drugs named most often in its trials are Bupivacaine. The most-studied condition is Anterior Cruciate Ligament Injury.

ClinicalTrials.gov trials by status

  • Recruiting350%
  • Not yet open233%
  • By invitation117%

Trials by phase

  • Not applicable583%
  • Observational117%
01

Clinical trials sponsored by Umraniye Education and Research Hospital

6 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
Effects of Malnutrition on Respiratory and Renal Functions in Patients Undergoing Peroral Endoscopic Myotomy (POEM)
NCT06405412 · ClinicalTrials.gov ↗ · Esophageal Achalasia
Observational Recruiting 2023-11 Turkey
The Effects of VC Versus PC Ventilation on Cerebral and Respiratory Parameters in Patients Undergoing Laparoscopic Gynecologic Surgery
NCT06482983 · ClinicalTrials.gov ↗ · Anesthesia, Gynecologic Cancer, Mechanical Ventilation Complication
Not applicable Recruiting 2023-05 Turkey
Paragastric Block for Pain and PONV in Sleeve Gastrectomy
NCT07274215 · ClinicalTrials.gov ↗ · Postoperative Nausea and Vomiting, Postoperative Pain After Laparoscopic Sleeve Gastrectomy
Not applicable Recruiting 2025-10 Turkey
Effect of Tourniquet Use on the Pivot Shift Test
NCT07831941 · ClinicalTrials.gov ↗ · Anterior Cruciate Ligament Injury
Not applicable Not yet open 2026-09 Turkey
Low and Moderete Flow Anaesthesia on Haemodynamics
NCT06871371 · ClinicalTrials.gov ↗ · Hemodynamics Instability, Arrhythmias Cardiac, Cerebral Oxygenation
Not applicable Not yet open 2025-03 Turkey
The Effectiveness of a Parent Training Program for Children With Autism Spectrum Disorder and High-Risk Infants: A Case-Control Study
NCT07075614 · ClinicalTrials.gov ↗ · Autism Disorder
Not applicable By invitation 2024-07 Turkey

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Drugs in Umraniye Education and Research Hospital trials

1 compound

Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.

03

Conditions in Umraniye Education and Research Hospital trials

11 conditions
Anterior Cruciate Ligament Injury1Esophageal Achalasia1Anesthesia1Gynecologic Cancer1Mechanical Ventilation Complication1Postoperative Nausea and Vomiting1Postoperative Pain After Laparoscopic Sleeve Gastrectomy1Hemodynamics Instability1Arrhythmias Cardiac1Cerebral Oxygenation1Autism Disorder1
04

By trial register

RegisterTrialsRecruiting
Clinical trials in Turkey63

A trial with sites in more than one country appears in each of those registers.

05

Other sponsors in Anterior Cruciate Ligament Injury

SponsorTrials
Miach Orthopaedics2
University of Pittsburgh1

Sponsors with the most current trials registered for this condition.

06

Questions about Umraniye Education and Research Hospital trials

How many clinical trials does Umraniye Education and Research Hospital sponsor?

Umraniye Education and Research Hospital is the lead sponsor of 6 current trials on ClinicalTrials.gov in our Turkey register, as of the registry sync on 14 November 2026. Completed and withdrawn studies are not counted.

Are Umraniye Education and Research Hospital trials recruiting?

Yes. 3 of its 6 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Which drugs is Umraniye Education and Research Hospital testing?

Its current trials name 1 drug or biological as interventions. The most frequent are Bupivacaine (1). The number in brackets is how many of its trials name each drug.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 14 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.